Evidence map›Paper›PMID 34840954›Full record

ArticleIDCases2021

Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer.

Aya Kitaoka, Kazuya Tanimura, Yuto Yasuda, Kensuke Nishioka, Yutaka Hirayama, Kiyoshi Uemasu, Daisuke Iwashima, Sou Arita, Toshiyuki Kitai, Susumu Hoshi and 3 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Aya KitaokaDepartment of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
Kazuya TanimuraDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuto YasudaDepartment of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
Kensuke NishiokaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yutaka HirayamaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kiyoshi UemasuDepartment of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
Daisuke IwashimaDepartment of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
Sou AritaMedical economics division, Health insurance bureau, Ministry of Health, Labour and Welfare, Japan.
Toshiyuki KitaiDepartment of Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, Japan.
Susumu HoshiDepartment of Gastroenterology, Kishiwada City Hospital, Kishiwada, Japan.
Emi DateDepartment of Pathology, Kishiwada City Hospital, Kishiwada, Japan.
Norishige IizukaDepartment of Pathology, Kishiwada City Hospital, Kishiwada, Japan.
Ken-Ichi TakahashiDepartment of Respiratory Medicine, Kishiwada City Hospital, Kishiwada, Japan.
Kishiwada City Hospital · JPKyoto University · JPKishiwada Tokushukai Hospital · JPMinistry of Health Labour and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the first cycle of carboplatin/etoposide treatment, febrile neutropenia and grade 4 neutropenia developed. Because diarrhea, abdominal pain, and bloody stool were observed, abdominal computed tomography was performed, showing intussusception, and extensive colectomy and colostomy were performed. Histopathology of the colon revealed gastrointestinal necrosis and perforation due to

Indexed as

ActivationChemotherapyEntamoeba histolyticaFulminant amebic colitisSmall-cell lung cancer

Identifiers

PMID34840954
PMCPMC8605421
OpenAlexW3214577655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.